1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Denmark >
  5. Clinical Microbiomics Acquires MS-Omics

M&A Deal Summary

Clinical Microbiomics Acquires MS-Omics

On October 17, 2022, Clinical Microbiomics acquired life science company MS-Omics

Acquisition Highlights
  • This is Clinical Microbiomics’ 1st transaction in the Life Science sector.
  • This is Clinical Microbiomics’ 1st transaction in Denmark.

M&A Deal Summary
Date 2022-10-17
Target MS-Omics
Sector Life Science
Buyer(s) Clinical Microbiomics
Deal Type Add-on Acquisition

Target

MS-Omics

Vedbæk, Denmark
MS-Omics is a service provider of metabolomics and data analysis that supports your analysis needs, from small to large studies. MS-Omics was founded in 2014 and is based in Vedbæk, Denmark.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Clinical Microbiomics

Copenhagen, Denmark
Category Company
Founded 2015
Sector Life Science
DESCRIPTION

Clinical Microbiomics is a contract research organization specializing in microbiome and metabolome analysis. Clinical Microbiomics was founded in 2015 and is based in Copenhagen, Denmark.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 2
Country: Denmark M&A 1 of 2
Year: 2022 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-01 DNASense

Aalborg, Denmark

DNASense is a microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics. DNASense was founded in 2014 and is based in Aalborg, Denmark.

Buy -
Mergr

Solution for

Product

Company

Legal